Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Inspire Veterinary Partners (IVPR) Gains from Investment Securities (2023 - 2025)

Historic Gains from Investment Securities for Inspire Veterinary Partners (IVPR) over the last 3 years, with Q3 2025 value amounting to $192061.0.

  • Inspire Veterinary Partners' Gains from Investment Securities fell 1877.96% to $192061.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $192061.0, marking a year-over-year decrease of 1877.96%. This contributed to the annual value of $236469.0 for FY2024, which is N/A changed from last year.
  • Latest data reveals that Inspire Veterinary Partners reported Gains from Investment Securities of $192061.0 as of Q3 2025, which was down 1877.96% from $192061.0 recorded in Q2 2025.
  • In the past 5 years, Inspire Veterinary Partners' Gains from Investment Securities registered a high of $236469.0 during Q3 2024, and its lowest value of -$188952.0 during Q1 2023.
  • Its 3-year average for Gains from Investment Securities is $116687.0, with a median of $192061.0 in 2025.
  • Examining YoY changes over the last 5 years, Inspire Veterinary Partners' Gains from Investment Securities showed a top increase of 1877.96% in 2025 and a maximum decrease of 1877.96% in 2025.
  • Quarter analysis of 3 years shows Inspire Veterinary Partners' Gains from Investment Securities stood at -$188952.0 in 2023, then surged by 225.15% to $236469.0 in 2024, then fell by 18.78% to $192061.0 in 2025.
  • Its last three reported values are $192061.0 in Q3 2025, $192061.0 for Q2 2025, and $151796.0 during Q1 2025.